JANET BARCARSE: Open Payments
NPI 1053935494 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 43 payments from 9 companies in 2025. Trend: 2023 $2,501 · 2024 $644 · 2025 $934
Food & beverage: $874Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $288 |
| GlaxoSmithKline, LLC. | 14 | $209 |
| GENZYME CORPORATION | 10 | $143 |
| Stryker Corporation | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 1 | $60 |
| Medtronic, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Lilly USA, LLC | 2 | $47 |
| Phadia US Inc. | 1 | $14 |
Products named: NUCALA, DUPIXENT, BOTOX, QULIPTA, PROPEL, TEZSPIRE, CORE, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
